2022
DOI: 10.1007/s12029-022-00875-3
|View full text |Cite
|
Sign up to set email alerts
|

The Psychometric Properties of the Fear of Progression Questionnaire (FoP-Q) for Cancer Patients in Iran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 62 publications
0
4
0
Order By: Relevance
“…Two studies reported fear of cancer recurrence (Hasannezhad Reskati et al, 2020; Johns et al, 2020). Owing to the unexplainable high heterogeneity between these two studies, data pooling was abandoned.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Two studies reported fear of cancer recurrence (Hasannezhad Reskati et al, 2020; Johns et al, 2020). Owing to the unexplainable high heterogeneity between these two studies, data pooling was abandoned.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, the review only included studies conducted in Iran, which affected the comprehensiveness and representativeness of its findings. However, the results of the review showed that ACT is effective in reducing anxiety and depression and promoting quality of life (Hasannezhad Reskati et al, 2018). These reviews have focused on diseases and quantification and only on evaluating benefits and disadvantages.…”
mentioning
confidence: 99%
“…The reliability (Cronbach's α > 0.7) and validity of this scale (with coefficients 0.77-0.94) were confirmed (30). The scale was approved for cancer patients in Iran by Hasannezhad Reskati et al in 2022 (31). The questionnaires were filled out twice before and immediately after the study by self-reporting.…”
Section: Instrumentsmentioning
confidence: 77%
“…Participants rated each item (e.g., “Being nervous prior to doctor’s appointment or periodic examinations”) using a 5-point Likert-scale from 1 (never) to 5 (very often). The Persian version of the FOP-Q-12 had acceptable reliability and validity for patients with cancer in Iran [ 49 ].…”
Section: Methodsmentioning
confidence: 99%